Medindia

X

FDA Issues Warning About Abnormal Heart Rhythm Drug Multaq

by Kathy Jones on  July 22, 2011 at 7:54 PM Drug News   - G J E 4
The US Food and Drug Administration has warned on Thursday that taking the abnormal heart rhythm drug Multaq may prove fatal.
 FDA Issues Warning About Abnormal Heart Rhythm Drug Multaq
FDA Issues Warning About Abnormal Heart Rhythm Drug Multaq
Advertisement

The drug was approved by the FDA to treat patients with short-term arrhythmia lasting less than six months and the health agency said that over 241,000 Americans may have been prescribed the medicine.

Advertisement
The warning comes following a study that looked into the drug's effectiveness among patients who have the long-term form of the disease, known as atrial fibrillation.

The FDA revealed that the study found twice as many deaths occurring among patients who took the drug compared to those who did not take it.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All